Effervescent Tablet Market Report 2026

Effervescent Tablet Market Overview

• Effervescent Tablet market size has reached to $39.6 billion in 2025 • Expected to grow to $66.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Growing Geriatric Population Fuels Effervescent Tablet Market Expansion • Market Trend: INJA Wellness Launches India's First Liposomal Glutathione Effervescent tablets-global-market-report" target="_blank">tablets • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Effervescent Tablet Market?

Effervescent tablets are the solid dosage form of tablets that are engineered to break down faster when they come into contact with water by releasing carbon dioxide. The tablets entirely disintegrate in a matter of minutes, releasing the medication into solution. The main products of effervescent tablets are medication and supplements. Medication refers to any drug, medical preparation, or remedy used to treat biological abnormalities and illnesses. The methods involved in the preparation of effervescent tablets are dry methods and wet granulation, which are used for indications including diuretics, pain management, gastric disorders, respiratory diseases, and others. It is applied to dental products, dietary supplements, pharmaceuticals, and others by various end-users such as hospitals, specialty clinics, home care, and others.

What Is The Effervescent Tablet Market Growth Forecast?

The effervescent tablet market size is expected to see rapid growth in the next few years. It will grow to $66.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expansion of personalized medicine, rising adoption of nutraceuticals, technological advancements in effervescent tablet delivery, growing geriatric population, increasing demand for pediatric formulations. Major trends in the forecast period include fast-dissolving formulations, personalized dosage solutions, functional & nutraceutical effervescent tablets, pediatric & geriatric focused tablets, enhanced flavor & consumer acceptability.

What Is The Driver Of The Effervescent Tablet Market?

The increase in the geriatric population is expected to boost the growth of the effervescent tablet market going forward. The geriatric population refers to the percentage of people 65 and older compared to those between the ages of 18 and 64 who are employed. The rise in the elderly population provides a lucrative market prospect for effervescent tablets, meeting the distinctive healthcare needs and preferences of this demographic with formulation advantages, user-friendly administration, and customization options that render them an attractive choice for effective and convenient healthcare solutions. For instance, in October 2025, the World Health Organization, a Switzerland based international public health agency, stated that, according to the WHO Ageing & Health fact sheet, by 2030 one in six people globally will be aged 60 years or older; by 2050, the number of people aged 60+ is projected to double to 2.1 billion, and the population aged 80+ is expected to triple to 426 million. Therefore, the increase in the geriatric population is driving the growth of the effervescent tablet industry.

Key Players In The Global Effervescent Tablet Market

Major companies operating in the effervescent tablet market are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company PLC, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Tower Laboratories Ltd., American Health, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Nestle SA, Dr Reddy's Laboratories Ltd.

Global Effervescent Tablet Market Trends and Insights

Major companies operating in the effervescent tablet market are focusing on developing advancement such as Liposomal Glutathione Effervescent Tablets to enhance bioavailability, improve antioxidant delivery, and cater to growing consumer demand for convenient and effective health supplements. Liposomal Glutathione Effervescent Tablets combine enhanced absorption technology with antioxidant properties, offering a convenient and effective way to support immune function, detoxification, and overall health. For instance, in August 2024, INJA Wellness is a US-based company focuses on wellness products, including supplements that promote health and vitality launched Liposomal Glutathione Effervescent Tablets. Liposomal Glutathione Effervescent Tablets utilize advanced liposomal technology to enhance the absorption of glutathione, a powerful antioxidant and are designed to dissolve in water for convenient consumption, supporting immune health.

What Are Latest Mergers And Acquisitions In The Effervescent Tablet Market?

In February 2024, EffRx Pharmaceuticals SA, a Switzerland-based pharmaceutical company including effervescent tablets partnered with Lupin Limited. With this partnership, EffRx Pharmaceuticals SA aims for the commercialization of BINOSTO(alendronate 70 mg effervescent tablets) by Lupin in Vietnam and the Philippines which is used primarily for treating postmenopausal osteoporosis in women. Lupin Limited is an India-based pharmaceutical company.

What Defines the Effervescent Tablet Market?

The effervescent tablet market consists of sales of prescription-based tablets and daily-used tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Effervescent Tablet Market Report 2026?

The effervescent tablet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent tablet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.